FY2024 EPS Estimates for Ayr Wellness Lowered by Analyst

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Stock analysts at Atb Cap Markets decreased their FY2024 EPS estimates for Ayr Wellness in a research report issued to clients and investors on Wednesday, November 13th. Atb Cap Markets analyst F. Gomes now expects that the company will post earnings of ($1.34) per share for the year, down from their prior forecast of ($1.15). Atb Cap Markets has a “Strong Sell” rating on the stock. The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.30) per share. Atb Cap Markets also issued estimates for Ayr Wellness’ Q4 2024 earnings at ($0.29) EPS and FY2025 earnings at ($0.98) EPS.

AYRWF has been the subject of a number of other research reports. Roth Mkm reduced their target price on Ayr Wellness from $3.50 to $3.00 and set a “buy” rating for the company in a research note on Thursday. Roth Capital raised Ayr Wellness to a “strong-buy” rating in a report on Friday, November 8th.

Ayr Wellness Stock Down 1.3 %

Shares of AYRWF stock opened at $0.77 on Monday. The stock’s fifty day moving average price is $1.82 and its 200 day moving average price is $1.98. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.59 and a quick ratio of 0.67. Ayr Wellness has a 1-year low of $0.71 and a 1-year high of $4.09. The company has a market cap of $87.90 million, a price-to-earnings ratio of -0.35 and a beta of 2.00.

About Ayr Wellness

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.